<DOC>
	<DOC>NCT02295592</DOC>
	<brief_summary>TSTstarr+ in the treatment of severe hemorrhoids prolapse--A multi center randomized controlled clinical trial.The aim of this stuy is to compare the first year hemorrhoids recurrence rate of TSTstarr+ and PPH in the treatment of severe hemorrhoids.</brief_summary>
	<brief_title>TSTstarr + for Treatment of Severe Prolapsed Hemorrhoids --- a Multi-center Randomized Controlled Clinical Trail</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhoids</mesh_term>
	<criteria>severe prolapsed hemorrhoids no significant analmalformation before operation having signed the informed consent. needing emergency operation or having previous history of hemorrhoids operation with other anal diseases at the same time such as : anal fissure, anal fistula and perianal abscess and so on diagnosed with inflammatory bowel disease or proctitis diagnosed with colorectal cancer associated with cardiovascular and cerebrovascular diseases and other diseases so that can not tolerate surgery or increase the risk of surgery with chronic or acute renal insufficiency patients coagulation abnormalities or with anticoagulation treatment at present diagnosed with diabetes with poor glycemic control in women with pregnant or menstruation The intellectual disabilities or mental disorder had participated in other clinical trial before we selected 4 weeks other severe complications.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>hemorrhoids</keyword>
	<keyword>The recurrence rate</keyword>
	<keyword>PPH</keyword>
	<keyword>TSTstarr+</keyword>
</DOC>